Zeltiq Aesthetics Inc. (ZLTQ) Shares Up 3.7%
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) shot up 3.7% during mid-day trading on Wednesday . The company traded as high as $32.47 and last traded at $31.46, with a volume of 1,064,322 shares changing hands. The stock had previously closed at $30.35.
A number of brokerages have recently issued reports on ZLTQ. Piper Jaffray Cos. reiterated an “overweight” rating and set a $40.00 price target on shares of Zeltiq Aesthetics in a research report on Monday, May 2nd. Brean Capital reiterated a “buy” rating on shares of Zeltiq Aesthetics in a research report on Thursday, April 28th. TheStreet upgraded Zeltiq Aesthetics from a “hold” rating to a “buy” rating in a research report on Wednesday, April 20th. Goldman Sachs Group Inc. lifted their price target on Zeltiq Aesthetics from $35.00 to $37.00 in a research report on Friday, April 8th. Finally, Leerink Swann reissued a “buy” rating on shares of Zeltiq Aesthetics in a report on Thursday, June 30th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $36.25.
The company has a market cap of $1.23 billion and a price-to-earnings ratio of 37.62. The company has a 50-day moving average price of $28.09 and a 200 day moving average price of $26.13.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its quarterly earnings results on Tuesday, May 10th. The company reported ($0.25) EPS for the quarter, hitting analysts’ consensus estimates of ($0.25). During the same quarter in the previous year, the company earned ($0.06) EPS. The company earned $64.50 million during the quarter, compared to analysts’ expectations of $61.80 million. The business’s quarterly revenue was up 25.0% compared to the same quarter last year. Equities analysts predict that Zeltiq Aesthetics Inc. will post $0.01 earnings per share for the current fiscal year.
In other news, VP Bradley Hauser sold 3,000 shares of the company’s stock in a transaction dated Monday, July 11th. The stock was sold at an average price of $30.02, for a total value of $90,060.00. Following the completion of the transaction, the vice president now owns 47,184 shares of the company’s stock, valued at $1,416,463.68. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Several institutional investors have added to or reduced their stakes in the company. Wells Fargo & Company MN raised its position in Zeltiq Aesthetics by 765.2% in the fourth quarter. Wells Fargo & Company MN now owns 404,376 shares of the company’s stock worth $11,537,000 after buying an additional 357,636 shares during the period. Russell Frank Co raised its position in Zeltiq Aesthetics by 98.0% in the fourth quarter. Russell Frank Co now owns 211,197 shares of the company’s stock worth $6,044,000 after buying an additional 104,550 shares during the period. CAM Group Holding A S raised its position in Zeltiq Aesthetics by 100.0% in the fourth quarter. CAM Group Holding A S now owns 150,000 shares of the company’s stock worth $4,280,000 after buying an additional 75,000 shares during the period. Trexquant Investment LP acquired a new position in Zeltiq Aesthetics during the fourth quarter worth $1,640,000. Finally, EAM Investors LLC raised its position in Zeltiq Aesthetics by 3.5% in the fourth quarter. EAM Investors LLC now owns 78,374 shares of the company’s stock worth $2,236,000 after buying an additional 2,670 shares during the period.
ZELTIQ Aesthetics, Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.